[go: up one dir, main page]

NO20022973L - Oksazolidinoner som har en sulfoksiminfunksjonalitet - Google Patents

Oksazolidinoner som har en sulfoksiminfunksjonalitet

Info

Publication number
NO20022973L
NO20022973L NO20022973A NO20022973A NO20022973L NO 20022973 L NO20022973 L NO 20022973L NO 20022973 A NO20022973 A NO 20022973A NO 20022973 A NO20022973 A NO 20022973A NO 20022973 L NO20022973 L NO 20022973L
Authority
NO
Norway
Prior art keywords
oxazolidinones
sulfoximine
functionality
sulfoximine functionality
Prior art date
Application number
NO20022973A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022973D0 (no
Inventor
Jr Jackson B Hester
David L Alexander
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20022973D0 publication Critical patent/NO20022973D0/no
Publication of NO20022973L publication Critical patent/NO20022973L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20022973A 1999-12-21 2002-06-20 Oksazolidinoner som har en sulfoksiminfunksjonalitet NO20022973L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17191699P 1999-12-21 1999-12-21
PCT/US2000/032451 WO2001046185A1 (fr) 1999-12-21 2000-12-12 Oxazolidinones presentant une fonctionnalite sulfoximine et leur utilisation comme agents antimicrobiens

Publications (2)

Publication Number Publication Date
NO20022973D0 NO20022973D0 (no) 2002-06-20
NO20022973L true NO20022973L (no) 2002-08-20

Family

ID=22625632

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022973A NO20022973L (no) 1999-12-21 2002-06-20 Oksazolidinoner som har en sulfoksiminfunksjonalitet

Country Status (22)

Country Link
US (1) US20010046987A1 (fr)
EP (1) EP1242417A1 (fr)
JP (1) JP2003518117A (fr)
KR (1) KR20020067557A (fr)
CN (1) CN1221548C (fr)
AR (1) AR029211A1 (fr)
AU (1) AU782078B2 (fr)
BR (1) BR0016605A (fr)
CA (1) CA2389482A1 (fr)
CO (1) CO5251427A1 (fr)
CZ (1) CZ20022142A3 (fr)
EA (1) EA005567B1 (fr)
HU (1) HUP0203869A2 (fr)
IL (1) IL150348A0 (fr)
MX (1) MXPA02006233A (fr)
NO (1) NO20022973L (fr)
NZ (1) NZ519725A (fr)
PE (1) PE20010931A1 (fr)
PL (1) PL356478A1 (fr)
SK (1) SK7572002A3 (fr)
WO (1) WO2001046185A1 (fr)
ZA (1) ZA200204166B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
GB0108764D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
GB0108793D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
GB0108794D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compound
WO2002081470A1 (fr) * 2001-04-07 2002-10-17 Astrazeneca Ab Oxazolidinones contenant un groupe sulfonimide en tant qu'antibiotique
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
TW200403240A (en) 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
US6875784B2 (en) * 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
BRPI0409217A (pt) * 2003-04-09 2006-03-28 Pharmacia & Upjohn Co Llc derivados e análogos antimicrobianos da [3.1.0]bicicloexilfeniloxazolidinona
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
US7265140B2 (en) * 2003-09-23 2007-09-04 Pfizer Inc Acyloxymethylcarbamate prodrugs of oxazolidinones
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
CA2589250A1 (fr) * 2004-11-29 2006-06-01 Pharmacia & Upjohn Company Llc Utilisation de diazepine oxazolidinones comme agents antibacteriens
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (fr) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention et traitement de troubles thromboemboliques
ATE449773T1 (de) 2005-06-29 2009-12-15 Pharmacia & Upjohn Co Llc Homomorpholinoxazolidinone als antibakterielle mittel
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
RU2578602C2 (ru) 2005-10-04 2016-03-27 Байер Интеллектуэль Проперти Гмбх Способ получения 5-хлор-n-(5s)-2-оксо-3-[4-(3-оксо-морфолинил)-фенил]-1,3-оксазолидин-5-ил}-метил)-2-тиофенкарбоксамида в модификации ii (варианты)
DE102007028319A1 (de) * 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
WO2021184339A1 (fr) * 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Composé d'oxazolidinone et procédés d'utilisation de celui-ci comme agent antibactérien

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
ATE233766T1 (de) * 1994-11-15 2003-03-15 Upjohn Co Antibakterielle bizyklische oxazin und thiazin- oxazolidinone
CA2228647A1 (fr) * 1995-09-01 1997-03-13 Pharmacia & Upjohn Company Pheniloxazolidinones presentant une liaison c-c avec des structures heterocycliques a 4-8 elements
NZ501412A (en) * 1997-05-30 2001-11-30 Upjohn Co Oxazolidinone antibacterial agents having a thiocarbonyl functionality

Also Published As

Publication number Publication date
JP2003518117A (ja) 2003-06-03
CN1221548C (zh) 2005-10-05
EP1242417A1 (fr) 2002-09-25
CO5251427A1 (es) 2003-02-28
NZ519725A (en) 2004-05-28
PL356478A1 (en) 2004-06-28
US20010046987A1 (en) 2001-11-29
CA2389482A1 (fr) 2001-06-28
CN1391572A (zh) 2003-01-15
AU782078B2 (en) 2005-06-30
NO20022973D0 (no) 2002-06-20
BR0016605A (pt) 2003-02-25
PE20010931A1 (es) 2001-08-29
AR029211A1 (es) 2003-06-18
IL150348A0 (en) 2002-12-01
MXPA02006233A (es) 2002-12-05
CZ20022142A3 (cs) 2002-11-13
WO2001046185A1 (fr) 2001-06-28
KR20020067557A (ko) 2002-08-22
EA005567B1 (ru) 2005-04-28
HUP0203869A2 (hu) 2003-07-28
EA200200699A1 (ru) 2003-02-27
SK7572002A3 (en) 2002-12-03
ZA200204166B (en) 2003-10-29
AU2050201A (en) 2001-07-03

Similar Documents

Publication Publication Date Title
NO20022973D0 (no) Oksazolidinoner som har en sulfoksiminfunksjonalitet
DE60314124D1 (de) 2-(2,6-dichlorphenyl)-diarylimidazole
ITMI20001803A0 (it) Dispensatore a doppia funzione
DE50007817D1 (de) Mikrospiegel
NO20051688D0 (no) Farmasoytiske blandinger som har en modifisert baerer
NO20015078L (no) Sulfonamidderivater som har oksadiazolringer
NO20000693D0 (no) Festeanordning
NO20041165L (no) Avstengningsanordning.
NO20030100D0 (no) Pleuromutilinderivater som har antibakteriell aktivitet
DK1026405T3 (da) Fastgørelsesanordning
BR0101990B1 (pt) dispositivo elÁstico de suspensço de uma estrutura vibratària em uma estrutura rÍgida.
IT1318923B1 (it) Pompa a doppia membrana - compatta
ITTO20030507A1 (it) Premistoppa a tenuta di fango.
DE60208495D1 (de) Kontrastphantom
IT1309591B1 (it) Composizioni a rilascio controllato di betaistina.
DE60111415D1 (de) Nagelschneider
IT1317768B1 (it) Disposizione di azionamento con un dispositivo di regolazione.
DE502004004887D1 (de) Zangenaggregat einer kämmaschine
DE50004387D1 (de) Schliessvorrichtung
IT1318610B1 (it) Micomelanine a struttura polinaftoica.
DE59912578D1 (de) Turbomaschinenschaufel
IT1313589B1 (it) Composizioni a rilascio controllato di paracetamolo.
DK1380585T3 (da) Pyrazolopyridinon som mellemprodukt
ITMO990082A0 (it) Mezzi a gancio.
NO20053100D0 (no) System for a kontrollere glatthet.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application